CD74 Antibody Conjugated to an MCL1 Inhibitor (S227928) Combines Synergistically with Venetoclax to Enhance Killing of Acute Myeloid Leukemia

被引：0
|
作者：
Moujalled, Donia M. [1 ,2 ]
Pomilio, Giovanna [1 ,2 ]
Morley, Thomas [1 ,2 ]
Litalien, Veronique [1 ,2 ]
Anstee, Natasha S. [1 ,2 ]
Loo, Sun [1 ,2 ,3 ,4 ]
Yeoh, Zhi-Han [1 ,2 ,3 ,4 ]
Boibessot, Clovis [3 ,4 ,5 ]
Bresson, Laura [3 ,4 ,5 ]
Maragno, Ana-Leticia [3 ,4 ,5 ]
Liot, Caroline [3 ,4 ,5 ]
Wei, Andrew H. [1 ,5 ,6 ,7 ,8 ]
机构：
[1] Walter & Eliza Hall Inst Med Res, Melbourne, Australia
[2] Univ Melbourne, Dept Med Biol, Melbourne, Australia
[3] Peter Maallum Canc Ctr, Dept Clin Haematol, Melbourne, Australia
[4] Royal Melbourne Hosp, Melbourne, Australia
[5] Inst Rech Servier, Oncol Res & Dev Unit, Gif Sur Yvette, France
[6] Royal Melbourne Hosp, Dept Clin Haematol, Melbourne, Australia
[7] Royal Melbourne Hosp, Melbourne, Australia
[8] Univ Melbourne, Melbourne, Australia
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-202691
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4136 / 4137
页数：2
相关论文
共 7 条
  • [1] S227928: A Novel Anti-CD74 ADC with MCL-1 Inhibitor Payload for the Treatment of Acute Myeloid Leukemia (AML) and Other Hematologic Malignancies
    Maragno, Ana-Leticia
    Seiss, Katherine
    Newcombe, Rick
    Mistry, Prakash
    Schnell, Christian R.
    Von Arx, Fabian
    Koenig, Julie
    Malamas, Anthony S.
    Le Toumelin-Braizat, Gaetane
    Bresson, Laura
    Rocchetti, Francesca
    Demarles, Didier
    Kurth, Esther
    Renteria, Lorena
    Hainzl, Dominik
    Engelhardt, Volker
    Liot, Caroline
    Madelain, Vincent
    Kostova, Vesela
    Starck, Jerome-Benoit
    Valour, Damien
    Franzetti, Georges-Alain
    Colland, Frederic
    Vostiarova, Helena
    Tschantz, William R.
    Bachmann, Nicholas
    Palacio-Ramirez, Sebastian
    Burger, Matthew
    Campbell, Jennifer M.
    Chen, Zhuoliang
    Koenig, Robert
    Mcneill, Eric
    Mo, Ruowei
    Nakajima, Katsumasa
    Palermo, Mark
    Shen, Yiping
    Yu, Bing
    Zambrowski, Mark
    Zhang, Alan
    Zecri, Frederic
    Broniscer, Alberto
    Geneste, Olivier
    Horton, Kristin
    D'Alessio, Joseph A.
    BLOOD, 2024, 144 : 1381 - 1382
  • [2] Wnt/β-Catenin Inhibitor Combined with Venetoclax Synergistically Induce Apoptosis in Acute Myeloid Leukemia By Increasing the Degradation of MCL-1 Protein
    Pan, Mengya
    Sun, Menghua
    Zhou, Junjie
    Jiao, Changqing
    Chen, Enbo
    Wu, Zhonghui
    Ma, Xiaoyu
    Liu, Xiaoying
    Ge, Jian
    BLOOD, 2024, 144 : 5779 - 5780
  • [3] BMI1-inhibitor PTC596 in combination with MCL1 inhibitor S63845 or MEK inhibitor trametinib in the treatment of acute myeloid leukemia
    Seipel, K.
    Kopp, B.
    Bacher, U.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2020, : 30S - 30S
  • [4] The MCL1-specific inhibitor S63845 acts synergistically with venetoclax/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells
    Zhaodong Li
    Shuning He
    A. Thomas Look
    Leukemia, 2019, 33 : 262 - 266
  • [5] The MCL1-specific inhibitor S63845 acts synergistically with venetoclax/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells
    Li, Zhaodong
    He, Shuning
    Look, A. Thomas
    LEUKEMIA, 2019, 33 (01) : 262 - 266
  • [6] 225Ac-CD33 Radioimmunotherapy potently increases the sensitivity of resistant acute myeloid leukemia lines to the Bcl-2 inhibitor venetoclax by mediating a reduction in cellular Mcl-1 levels
    Garg, Ravendra
    Geoghegan, Eileen
    Allen, Kevin J.
    Dawicki, Wojciech
    Dadachova, Ekaterina
    Ludwig, Dale L.
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia
    Seipel, Katja
    Graber, Carolyn
    Fluckiger, Laura
    Bacher, Ulrike
    Pabst, Thomas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
1